Product Description: HDAC6-IN-42 (compound 2b) is an HDAC6 inhibitor (IC50=0.009 μM). HDAC6-IN-42 shows significant anti-leukemia activity and synergistic effect with Decitabine (HY-A0004). HDAC6-IN-42 can be used for the AML research[1].
Formula: C24H28FN3O4
References: [1]Tretbar M, et al. Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabine[J]. European Journal of Medicinal Chemistry, 2024: 116447.